ConductScience.org, home

Trial · NCT00388674

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Initial TreatmentSTARTEDEntecavir (ETV)6,216
Initial TreatmentSTARTEDOther Anti-HBV Medication (Non-ETV)6,162
Initial TreatmentCOMPLETEDEntecavir (ETV)4,388
Initial TreatmentCOMPLETEDOther Anti-HBV Medication (Non-ETV)3,576
Initial TreatmentNOT COMPLETEDEntecavir (ETV)1,828
Initial TreatmentNOT COMPLETEDOther Anti-HBV Medication (Non-ETV)2,586
End of StudySTARTEDEntecavir (ETV)6,216
End of StudySTARTEDOther Anti-HBV Medication (Non-ETV)6,162
End of StudyCOMPLETEDEntecavir (ETV)4,482
End of StudyCOMPLETEDOther Anti-HBV Medication (Non-ETV)3,993
End of StudyNOT COMPLETEDEntecavir (ETV)1,734
End of StudyNOT COMPLETEDOther Anti-HBV Medication (Non-ETV)2,169

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00388674/flow